Zevra Therapeutics, Inc.
Zevra Reports Third Quarter 2026 Financial Results and Corporate Update
$37.8 million net revenue for Q3 2026, driven by $34.0 million in revenue from MIPLYFFA
Company newsroom
Zevra Therapeutics, Inc.
1 releases
Company newsroom
1 releases
$37.8 million net revenue for Q3 2026, driven by $34.0 million in revenue from MIPLYFFA